Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lip and oral cavity cancer
Stage/Subtype:  stage II lip and oral cavity cancer
Trial Type:  Treatment
Results 1-14 of 14 for your search:
Start Over
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 603EUSA03, NCI-2010-01741, NCT00901732
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Docetaxel, Cisplatin, and Cetuximab in Treating Patients with Metastatic or Relapsed Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Azacitidine in Measuring Tumor Response in Patients with HPV Positive or Negative Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1404013771, NCI-2015-01437, 200 FR. 4 (2012-1), NCT02178072
Surgery with or without Stereotactic Body Radiotherapy in Treating Patients with Previously-Irradiated Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-151, NCI-2015-01424, NCT02516969
Pembrolizumab, Cisplatin, and Intensity Modulated Radiation Therapy in Treating Patients with Previously Untreated Stage III-IVb Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 15-132, NCI-2016-00793, NCT02777385
Afatinib Dimaleate and Radiation Therapy with or without Docetaxel in Treating Patients with Head and Neck Cancer Previously Treated with Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-267, NCI-2013-00626, NCT01783587
Biomarker Response to Cetuximab and VTX-2337 in Treating Patients with Stage II-IVA Head and Neck Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-002, NCI-2014-01430, UPCI #14-002, VRXP-A106, NCT02124850
Vaccine Therapy in Treating Patients with Stage I-IVA Head and Neck Squamous Cell Carcinoma That Have Undergone Surgery
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-160, NCI-2014-02500, 13-160, NCT02211027
Transoral Robotic Surgery in Treating Patients with Benign or Malignant Tumors of the Head and Neck
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: OSU-07061, NCI-2011-03122, 07061, NCT01473784
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Transoral Robotic Surgery in Treating Patients With Oropharyngeal, Hypopharyngeal, and Oral Cavity Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 20 and over
Trial IDs: HNO 0601, NCI-2011-03028, NCT00473564
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Durvalumab before Surgery in Treating Patients with Oral Cavity or Oropharynx Cancer
Status: Not yet active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 60116, NCI-2016-00639, NCT02827838
Start Over